Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.
暂无分享,去创建一个
S. Shirasawa | T. Sasazuki | H. Weiss | Jianli Dong | Eun Y. Lee | B. Evers | Y. Zaytseva | Ji Tae Kim | Pat Gulhati | Joe Valentino | Tianyan Gao | Payton D. Stevens | P. Gulhati